| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.49 | 0.1 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |